Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ZIVO 
Zivo Bioscience Inc (ZIVO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: ZIVO (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 365.65% | Avg. Invested days 48 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 64.28M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 401 | Beta 0.11 | 52 Weeks Range 3.13 - 22.15 | Updated Date 04/2/2025 |
52 Weeks Range 3.13 - 22.15 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.23 |
Earnings Date
Report Date 2025-03-13 | When After Market | Estimate -0.56 | Actual -0.36 |
Profitability
Profit Margin - | Operating Margin (TTM) -1773.8% |
Management Effectiveness
Return on Assets (TTM) -759.6% | Return on Equity (TTM) -3956.02% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 62994461 | Price to Sales(TTM) 408.87 |
Enterprise Value 62994461 | Price to Sales(TTM) 408.87 | ||
Enterprise Value to Revenue 400.68 | Enterprise Value to EBITDA -3.01 | Shares Outstanding 3759210 | Shares Floating 1338430 |
Shares Outstanding 3759210 | Shares Floating 1338430 | ||
Percent Insiders 50.32 | Percent Institutions 0.07 |
Analyst Ratings
Rating 3 | Target Price 12 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Zivo Bioscience Inc
Company Overview
History and Background
Zivo Bioscience Inc. was founded in 2006. Initially focused on algal biotechnology, it has evolved towards developing therapeutics and nutritional ingredients, specifically a proprietary algae strain for animal and human health.
Core Business Areas
- Animal Health: Developing and commercializing proprietary algae-based products for use in animal feed, aimed at improving animal health and productivity.
- Human Health: Exploring applications of its algae strain in human health, including potential therapeutic and preventative uses.
Leadership and Structure
The leadership team consists of individuals with expertise in biotechnology, pharmaceuticals, and business management. The organizational structure includes departments for research and development, operations, and commercialization, overseen by a board of directors.
Top Products and Market Share
Key Offerings
- DHAvA Oil: DHAvA oil is the main ingredient that the company produces. As of right now DHAvA oil is intended for poultry to improve the bird health. Market share is nearly non-existent as the company does not have many sales.
Market Dynamics
Industry Overview
The animal health market is growing, driven by increasing demand for protein and rising awareness of animal welfare. The human health market for algal-based products is also expanding due to the perception of health benefits.
Positioning
Zivo Bioscience Inc. is a small player in the animal and human health markets. Its competitive advantage lies in its proprietary algae strain and potential for unique applications.
Total Addressable Market (TAM)
The TAM for animal health is substantial, estimated in the billions of dollars globally. Zivo Bioscience Inc. is positioned to capture a small share through specialized products.
Upturn SWOT Analysis
Strengths
- Proprietary algae strain
- Potential for unique product applications
- Focus on niche markets
Weaknesses
- Limited financial resources
- Small market share
- Dependence on research and development success
Opportunities
- Expanding into new animal health markets
- Developing human health products
- Partnerships with larger companies
Threats
- Competition from established players
- Regulatory hurdles
- Potential for research and development failures
Competitors and Market Share
Key Competitors
- DSM (DSM.AS)
- BASF (BASF.DE)
- Cargill (Private)
Competitive Landscape
Zivo Bioscience Inc. faces intense competition from larger, more established companies. Its competitive advantage lies in its unique algae strain, but it needs to scale production and commercialization to compete effectively.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been slow due to reliance on Research and Development.
Future Projections: Future growth is dependent on successful commercialization of its products.
Recent Initiatives: Recent initiatives include efforts to commercialize its algae-based animal feed supplement.
Summary
Zivo Bioscience is a micro-cap biotechnology firm in a very competitive marketplace that needs to continue research and development to stay competitive. The company has a unique product in its algae strain, but needs to work towards commercialization. Zivo Bioscience Inc. requires additional funding to survive and has very minimal sales. It faces stiff competition from very large established players that currently have the existing market share.
Similar Companies
CRBP
Corbus Pharmaceuticals Holding
CRBP
Corbus Pharmaceuticals Holding
VALE
Vale SA ADR
VALE
Vale SA ADR
Sources and Disclaimers
Data Sources:
- SEC filings
- Company press releases
- Analyst reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Zivo Bioscience Inc
Exchange NASDAQ | Headquaters Bloomfield Hills, MI, United States | ||
IPO Launch date 2012-09-24 | President, CEO & Chairman of the Board Mr. John Bernard Payne | ||
Sector Healthcare | Industry Biotechnology | Full time employees 7 | Website https://www.zivobioscience.com |
Full time employees 7 | Website https://www.zivobioscience.com | ||
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.